Successful Management of Tachycardiac Atrial Fibrillation in a Septic Patient with Landiolol
- 1 January 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 100 (1), 294
- https://doi.org/10.1213/01.ane.0000140814.28118.6f
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- In rabbits, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmololCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2001
- Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting β-blocker, in patients with cardiac arrhythmiasClinical Pharmacology & Therapeutics, 2000